But coming from the reverse end, if we're setting policy as a government and we're saying to patients that we're going to force them to take a drug that doesn't work as well, that costs way more than the drug they want to take and it's the same molecule—and it's paid for by the taxpayers—can you not see that Canadians would have some real concerns about how this program is being managed if that's the result?
On October 30th, 2018. See this statement in context.